Page last updated: 2024-10-29

imipramine and EHS Tumor

imipramine has been researched along with EHS Tumor in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"The present study was conducted to examine whether a chronic variable stress procedure (CVS)--an animal model of depression--facilitates tumor growth, and whether this effect can be modified by concurrent administration of the antidepressant imipramine (IMI)."3.68Chronic variable stress facilitates tumoral growth: reversal by imipramine administration. ( Basso, AM; Depiante-Depaoli, M; Molina, VA, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basso, AM1
Depiante-Depaoli, M1
Molina, VA1

Other Studies

1 other study available for imipramine and EHS Tumor

ArticleYear
Chronic variable stress facilitates tumoral growth: reversal by imipramine administration.
    Life sciences, 1992, Volume: 50, Issue:23

    Topics: Animals; Cyclosporine; Depression; Disease Models, Animal; Imipramine; Immune Tolerance; Immunity; M

1992